Christine Cassiano

Senior Vice President, Corporate Communications and Investor Relations

With a dual background in investor and public relations, Ms. Cassiano has an extensive history developing innovative approaches that advance communications in corporate positioning, issues management, employee engagement, commercialization and investor relations. Ms. Cassiano was previously Head of Healthcare for the W2O Group, an integrated healthcare marketing and communications consulting firm. She previously co-founded ARC2 Communications & Media, a boutique agency that developed groundbreaking platforms for some of the largest companies in healthcare. Her more than 20-year career includes multiple product launches across various therapeutic areas such as Botox®/Botox® Cosmetic (onabotulinumtoxinA), Prolia® (denosumab), Abraxane® (paclitaxel) and Lumigan® (bimatoprost ophthalmic solution) as well as leading global efforts as Senior Vice President & Co-Director, Healthcare at Hill + Knowlton Strategies. Ms. Cassiano has held senior communications roles at biotechnology and pharmaceutical companies such as Amgen, Allergan and Abraxis BioScience. Some of Ms. Cassiano’s career achievements include a SABRE Silver Anvil award for the launch of Botoxâ Cosmetic (Allergan), an In2 SABRE Award for the Most Innovative Brand/Agency Collaboration (Pfizer/ARC2), and PR Week’s 40 Under 40.